Syed Mian

Research fellow @TheCrick #BMStemCells🩸#BMNiche #MDS #Cancer #CureForMDS @MDSfoundation-YI, #EHA-ASH TRTH2025 Fellow
Opinions are my own!

[Shahram Kordasti @SKordasti]

📢 Fully funded PhD opportunity, starting Autumn 2027!

🔬 Engineering FAS resistant, bone marrow homing Tregs for hypoplastic MDS, combining Treg engineering, hypoxia responsive CXCR4 and immunotherapy.

KCL + UCL | CRUK City of London Centre

👇
https://t.co/87wrqFtvBX

#PhD #Tregs #MDS #Immunotherapy

[Shahram Kordasti @SKordasti]

📢 یک فرصت دکتری برای شروع در پاییز ۲۰۲۷

پروژه ما روی مهندسی سلول‌های Treg مقاوم به FAS و با قابلیت هدف‌گیری مغز استخوان برای درمان hypoplastic MDS است؛ ترکیبی از ایمونولوژی سرطان، مهندسی سلولی و ایمونوتراپی.
پروژه مشترک با همکارم پروفسور سارا قریشیان در دانشگاه UCL.

https://t.co/v9HgdQXTN1

KCL + UCL | CRUK City of London Centre

👇
https://t.co/87wrqFtvBX

#PhD #CancerImmunology #Treg #MDS

[Simona Valletta @Dr_Valletta]

📢 Fully funded clinical PhD studentship available in my group! @MCRCnews @CR_UK @OfficialUoM
❓Can we wake up an ageing immune system to fight leukaemia? Our preliminary data suggest yes! 😎
More details at the link 👉https://t.co/HJ3lLbkGV0

[Daniel Starczynowski @dstarczynowski]

We’re recruiting tenure-track faculty in leukemia research @CincyChildrens . Join the Advanced Leukemia Therapies and Research Center - a collaborative community spanning discovery science, translational research, and clinical investigation.
https://t.co/ibGASvQh8q

[Syed Mian @BMiDynamics]

@keisuke_ito_lab @TheCrick @QMBCI @GabriellaFicz @UCLResearch @EinsteinMed @Einstein_SCI It was lovely to have you at the @TheCrick ! Amazing science and brilliant talk!

[Syed Mian @BMiDynamics]

Thank you so much to @bloodcancer_uk and everyone in the community who makes vital blood cancer research possible. ❤️

I’m incredibly grateful to BCUK for funding my future work and establish 🚨 My Research Lab🚨 !!!

🚦 More news to follow soon 🚦 !

Super excited 🩸��👥🔬❤️.

[Blood Cancer UK @bloodcancer_uk]

As a child, Dr Mian spent years attending hospital appointments because of a blood disorder. Those experiences now shape his own research.

We're proud to fund @BMiDynamics research into MDS, a group of blood conditions that start in the bone marrow where blood cells are made.

[Syed Mian @BMiDynamics]

@kamilkranc @CR_UK Congratulations @kamilkranc and team!

[Kamil R Kranc @kamilkranc]

Delighted to see our new paper out today in Science Advances! We identify TUT4/7 as therapeutic targets in AML: their deletion or inhibition compromises AML while largely sparing normal haematopoiesis. Thanks to our collaborators & @CR_UK!
https://t.co/dG0onuD9Nj

[Blood Cancer UK Research @BloodCancer_Res]

🎉 We’ve passed the @AMRC Expert Review Audit!

Meeting AMRC's six principles of expert review confirms that we use robust and rigorous research funding processes, helping us to fund the best research and driving better health outcomes for the blood cancer community 🩸

[Mick Milsom @MilsomMick]

Register for @ISEHSociety annual meeting today, and get the chance to pocket some merch!

[Vijay Sankaran @bloodgenes]

Congratulations to this amazing group of recipients!!! 👏👏

[Syed Mian @BMiDynamics]

Thank you, @hemasphere, for this recognition and for your continued support of excellence in research. We are truly grateful and look forward to continuing our collaboration with the journal.

[HemaSphere Journal (prelim IF = 11.3) @Hemasphere_EHA]

At #EHA2026, the #HemaSphereAwards recognize authors of influential hematology publications. Congratulations to Syed A Mian, Linda Ariza-McNaughton, & coauthors for their study on donor-recipient sex influence on engraftment of normal + leukemia stem cells👉https://t.co/ZIUsYQtzeP

[Blood Cancer UK Research @BloodCancer_Res]

We're proud to be one of 89 charities sharing
@NIHRresearch’s £37m investment in 800+ early-career researchers.

This funding will empower our researchers at crucial career stages to make the breakthroughs that save and improve lives ❤️

[Mick Milsom @MilsomMick]

For the first time, we have reserved an entire session for talks selected from the late breaking abstracts.

[European Hematology Association @EHA_Hematology]

Applications to join our joint EHA-ASH Translational Research Training in Hematology (TRTH) Program are open!

What can you expect?
• Translational research in practice: Interactive sessions on methodology and emerging research tools.
• Ethics and responsibility: Discussion of ethical and regulatory frameworks in Europe and North America.
• Career insight: Honest perspectives from leading hematologists.
• Small‑group mentoring: Daily breakout sessions with mentors, faculty, and peers.
• Proposal development: Structured opportunities to present and strengthen your research proposal.

Find out more and submit your LOI by June 18, 2026 (15:00 CET): https://t.co/g5zqCuIGgl

[Blood Cancer UK Research @BloodCancer_Res]

📢 Applications are currently open for our Early Career Advancement Fellowships 2026/27

Supporting future leaders in blood cancer research with awards of up to £450k over 3 years

📅 Deadline: 9 July 2026, 3pm

Apply now:
https://t.co/uieTcRfkW2

[Blood Cancer UK Research @BloodCancer_Res]

🚨 Applications are currently open for our Transformational Research Awards

We're funding ambitious blood cancer research, with awards of up to £1.5m over 5 years

📅 EOI deadline: 4 June 2026, 3pm

Find out more and apply:
https://t.co/FShr4Swp6o

[Syed Mian @BMiDynamics]

Interesting indeed! Analysis of papers from millions of scientists shows that older researchers tend to stick with ideas from their past.
https://t.co/3ixBY8DlJQ

[Leukaemia UK @LeukUK]

A simple full blood count would have diagnosed Mooni earlier and saved his family the horrendous torture of not knowing if he would ever wake up.

Join over 7,000 people in calling for the Government to end the delays in leukaemia diagnosis 👉 https://t.co/ajST79y7Oj

[Syed Mian @BMiDynamics]

https://t.co/8bIsMBwjCh